Susan Aldridge. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Cell Death/drug effectsClinical Trials, Phase III as TopicDiabetes Mellitus, Type 1/drug therapyDiabetes Mellitus, Type 1/economicsHumansIndustry/economicsInsulin-Secreting Cells/drug effectsInsulin-Secreting Cells/pathologyPeptides/chemical synthesisPeptides/therapeutic useToll-Like Receptors/antagonists & inhibitors
Substances: See more » PeptidesToll-Like Receptors
Year: 2012 PMID: 22318018 DOI: 10.1038/nbt0212-124c
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908